3644 results for «769»

Filter By

3644 results

Hybrid percutaneous revascularisation: combining DES and DCB for optimal results

21 May 2026 – From EuroPCR 2026

This session delves into hybrid percutaneous revascularisation techniques that combine drug-eluting stents (DES) and drug-coated balloons (DCB) to achieve optimal clinical results. It highlights the clinical and anatomical scenarios suited for hybrid PCI, provides a step-by-step procedural approach, and discusses the potential benefits of integrating these...

Hybrid percutaneous revascularisation: combining DES and DCB for optimal results

Assessing coronaries in ACS with intracoronary imaging

21 May 2026 – From EuroPCR 2026

This session highlights the critical role of intracoronary imaging in evaluating acute coronary syndromes (ACS). It discusses the management of complex lesion morphologies involving calcium and thrombus, the diagnostic power of OCT in decision-making, challenges beyond angiography in right coronary artery pathology, and the identification of...

Overcoming challenging anatomy in calcified lesion PCI

22 May 2026 – From EuroPCR 2026

This session focuses on overcoming the challenges posed by complex anatomical variations in calcified lesion PCI. Experts present advanced techniques and hybrid solutions for difficult bifurcation angles, aorto-ostial lesions, and other complex scenarios, emphasizing both innovative and simplified approaches to achieve procedural success.

TAVI sub-studies - Beyond the primary endpoint

21 May 2026 – From EuroPCR 2026

This session reviews key sub-studies from major TAVI trials that extend beyond primary endpoints to provide a deeper understanding of valve performance and patient outcomes. It covers comparisons between balloon-expandable and self-expanding valves, long-term real-world data on the Myval valve, echocardiographic outcomes, composite endpoint analyses, and...

TAVI sub-studies - Beyond the primary endpoint

New insights into pharmacological treatment for STEMI

21 May 2026 – From EuroPCR 2026

This session presents the latest pharmacological advances in the treatment of ST-segment elevation myocardial infarction (STEMI). It covers safety data on ticagrelor monotherapy post-primary PCI, the impact of P2Y12 inhibitor pretreatment, effects of dapagliflozin on myocardial remodeling, and considerations for bleeding risk and vascular preparation strategies...

From wires to knives: CABG essentials every cathlab nurse and allied professional should know

21 May 2026 – From EuroPCR 2026

This session is designed to equip cathlab nurses and allied professionals with essential knowledge about Coronary Artery Bypass Grafting (CABG). It covers the indications for CABG, relevant cardiovascular anatomy and physiology, and the importance of effective communication with patients undergoing CABG procedures. Practical walkthroughs of angiograms...

Spontaneous coronary artery dissection management with intracoronary imaging

22 May 2026 – From EuroPCR 2026

Explore the nuanced management of spontaneous coronary artery dissection (SCAD) with a focus on intracoronary imaging. This session examines diagnostic challenges, the limited role of coronary CT angiography, and strategies for managing occlusive SCAD cases, highlighting the evolving understanding of this complex condition.

Bifurcation failure: the realities and strategies for avoidance

21 May 2026 – From EuroPCR 2026

This session addresses the challenges associated with bifurcation lesion PCI, focusing on procedural complications, novel classification systems for in-stent restenosis, and plaque characterization near side branches. It reviews clinical outcomes of Drug-Coated Balloon (DCB) treatments for side branch lesions, the influence of drug-eluting balloon strategies, and...

New evidence for the use of DCB

20 May 2026 – From EuroPCR 2026

This session reviews emerging evidence supporting the use of drug-coated balloons (DCB) in complex PCI. It covers data from recent trials such as SELUTION De Novo, studies on vascular healing, restenosis patterns, long-term outcomes compared to DES, and optimal side branch treatment in bifurcation lesions.

New evidence for the use of DCB

Best complications on calcified lesions

20 May 2026 – From EuroPCR 2026

Highlighting challenging cases in calcified coronary lesions, this session presents a series of complications including stuck wires, the Kokeshi phenomenon, and multiple complications within a single vessel. It provides practical insights into rescue techniques and navigating complex procedural challenges.

Best complications on calcified lesions

Stentless PCI, DCB and BVS in complex scenarios

20 May 2026 – From EuroPCR 2026

This session explores the use of stentless percutaneous coronary interventions (PCI) employing drug-coated balloons (DCB) and bioresorbable scaffolds (BVS) in complex coronary scenarios. Through detailed case discussions, it addresses decision-making processes, technical considerations, and practical tips for successfully completing PCI without permanent stenting.

DCB - Going beyond in-stent restenosis

20 May 2026 – From EuroPCR 2026

This session examines the expanding role of drug-coated balloons (DCB) beyond in-stent restenosis, including treatment of acute coronary syndromes, calcified lesions, and bifurcations. It reviews current evidence supporting DCB-based revascularization and outlines essential procedural steps to optimize outcomes.

AI adoption in the cathlab of tomorrow - Risk prediction applications

20 May 2026 – From EuroPCR 2026

This session delves into the adoption of artificial intelligence in the cath lab, focusing on clinically useful risk prediction models for coronary and structural interventions. It covers advanced AI-guided intravascular imaging, machine learning applications for adverse event prediction, and critical evaluation of model validation and clinical...

DCB as a key player in the management of complex coronary lesions

21 May 2026 – From EuroPCR 2026

This session highlights the pivotal role of drug-coated balloons (DCB) in managing complex coronary lesions. Experienced operators share their approaches to applying DCB in challenging clinical and anatomical settings, optimized by intravascular imaging guidance. The discussion includes insights from the LatamBif Registry and other series on...

Complex endovascular and pulmonary interventions

20 May 2026 – From EuroPCR 2026

Explore advances in complex endovascular and pulmonary interventions, including the transformation of interventional labs into intelligent learning ecosystems, innovative approaches to peripheral and coronary CTOs, and novel therapies such as extravascular renal denervation and fixation catheters for acute pulmonary embolism.

First-in-human studies in cardiovascular devices: from first 10 patients to global innovation — How efficient early studies advance emerging technologies

20 May 2026 – From EuroPCR 2026

Understand the pivotal role of first-in-human studies in advancing cardiovascular device innovation through operational insights from early patient experiences. This session reviews cutting-edge technologies including percutaneous left ventricular assist devices, transcatheter leaflet augmentation, physiology-guided PCI, synchronized diaphragmatic stimulation, pulmonary artery denervation, and perspectives on translating early...

A new horizon in left main and multivessel PCI

21 May 2026 – From EuroPCR 2026

This session explores new horizons in managing left main and multivessel coronary artery disease with PCI. It covers comprehensive evaluation techniques, including physiology and imaging assessments, and advanced PCI strategies for challenging eccentric and heavily calcified lesions. Case presentations from diverse clinical contexts illustrate decision-making and...

Novel indications for DCB

21 May 2026 – From EuroPCR 2026

This session reviews emerging clinical applications for drug-coated balloons (DCB) beyond traditional indications. It covers outcomes in venous stenosis, aorto-ostial lesions, and coronary bifurcation disease, comparing DCB strategies with drug-eluting stents and highlighting recent clinical trial findings.

TAVI in heart failure is possible

21 May 2026 – From EuroPCR 2026

This session demonstrates the feasibility of transcatheter aortic valve implantation (TAVI) in patients with heart failure through a series of challenging cases. It covers sequential management of hypertrophic obstructive cardiomyopathy with aortic stenosis, advanced heart failure interventions, staged approaches in cardiogenic shock, and complex percutaneous interventions...

TAVI procedural complications - Part 9: coronary occlusion, difficult aortic valve crossing and more

21 May 2026 – From EuroPCR 2026

Explore the management of complex TAVI procedural complications, including coronary occlusion and difficult valve crossing. This session presents innovative bailout techniques, diagnostic challenges, and case-based discussions highlighting acute coronary syndrome post-TAVI and nuanced approaches to valve-in-valve interventions.

Didn’t find what you were looking for?